Evidence map›Paper›PMID 37289361›Full record

ArticleAging clinical and experimental research2023

Pan-immune inflammation value; a novel biomarker reflecting inflammation associated with frailty.

Arzu Okyar Baş, Merve Güner, Serdar Ceylan, Merve Hafızoğlu, Zeynep Şahiner, Burcu Balam Doğu, Meltem Gülhan Halil, Mustafa Cankurtaran, Cafer Balcı

Abstract read
PubMed Publisher
In one paragraph

Article in Aging clinical and experimental research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. A different perspective in trauma patients: can pan-immune-inflammation value (PIV) predict mortality?Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Frailty and Cognitive Decline in Hospitalized Elderly Patients: Associations with Clinical and Laboratory Parameters.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Arzu Okyar BaşDepartment of Internal Medicine, Division of Geriatrics, Hacettepe University Medical School, Altindag, Ankara, Turkey. arzu0506@hotmail.com.ORCID http://orcid.org/0000-0002-1518-5939
Merve GünerDepartment of Internal Medicine, Division of Geriatrics, Hacettepe University Medical School, Altindag, Ankara, Turkey.
Serdar CeylanDepartment of Internal Medicine, Division of Geriatrics, Hacettepe University Medical School, Altindag, Ankara, Turkey.
Merve HafızoğluDepartment of Internal Medicine, Division of Geriatrics, Hacettepe University Medical School, Altindag, Ankara, Turkey.
Zeynep ŞahinerDepartment of Internal Medicine, Division of Geriatrics, Hacettepe University Medical School, Altindag, Ankara, Turkey.
Burcu Balam DoğuDepartment of Internal Medicine, Division of Geriatrics, Hacettepe University Medical School, Altindag, Ankara, Turkey.
Meltem Gülhan HalilDepartment of Internal Medicine, Division of Geriatrics, Hacettepe University Medical School, Altindag, Ankara, Turkey.
Mustafa CankurtaranDepartment of Internal Medicine, Division of Geriatrics, Hacettepe University Medical School, Altindag, Ankara, Turkey.
Cafer BalcıDepartment of Internal Medicine, Division of Geriatrics, Hacettepe University Medical School, Altindag, Ankara, Turkey.
Hacettepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFrailty is suggested to be associated with age-related changes in the immune system, namely immunosenescence. Few studies have investigated the association of frailty with circulating immune biomarkers reflecting immunosenescence. Pan-immune inflammation value (PIV) is a new composite circulating immune biomarker to predict inflammation status.

aimThis study aimed to assess the relationship between PIV and frailty.

methodsA total of 405 geriatric patients were enrolled in the study. All participants underwent a comprehensive geriatric assessment. The comorbidity burden was evaluated with Charlson Comorbidity Index. Frailty status was evaluated via the Clinical Frailty Scale (CFS), and patients with CFS scores ≥ 5 were defined as living with frailty. PIV was calculated using the formula: (Neutrophil × monocyte × platelet)/lymphocyte. Patients were defined as PIV-low (≤ 372) and PIV-high (> 372).

resultsThe median age of participants was 72 (IQR = 67-78) years and; 63.0% (n = 225) were female. Patients were divided into two categories (i.e., robust and living with frailty groups), and 320 (79.0%) and 85 (21.0%) patients were in each group, respectively. Median PIV was higher in the living with frailty group (p = 0.008). In the linear and logistic regression analyses, both PIV and PIV-high (> 372) were significantly associated with frailty independently of confounders. DISCUSSION AND

conclusionThis is the first study revealing the relationship between PIV and frailty. PIV may be seen as a novel biomarker reflecting inflammation associated with frailty.

Indexed as

FrailtyImmunosenescenceAgedBiomarkersFemaleHumansImmune SystemInflammationMaleBiomarkersFrailtyImmunosenescenceInflammagingInflammationPan-immune inflammation value

Identifiers

PMID37289361
OpenAlexW4379768246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.